Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-Year Update

Clinical Lung Cancer · Elsevier

Аннотация

Publication date: December 2026 Source: Clinical Lung Cancer, Volume 27, Issue 10 Author(s): Hisao Imai, Teppei Yamaguchi, Koichi Azuma, Takashi Kijima, Yukihiro Toi, Kazuma Kishi, Kohei Fujita, Haruhiro Saito, Yoshimasa Shiraishi, Junko Tanizaki, Yuta Takashima, Yuichi Tambo, Satoshi Watanabe, Osamu Hataji, Tatsuro Fukuhara, Tomoyuki Ohsugi, Yu Tobishima, Hidehito Horinouchi

Читать у издателя →

Похожие статьи